ID

31686

Description

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC); ODM derived from: https://clinicaltrials.gov/show/NCT01326559 Collaborating Parties: The University of Hong Kong Sanofi Merck Sharp & Dohme Corp. Roche Pharma AG

Link

https://clinicaltrials.gov/show/NCT01326559

Keywords

Versions (2)
  1. 9/16/18 9/16/18 -
  2. 9/21/18 9/21/18 -
Copyright Holder

Hong Kong Nasopharyngeal Cancer Study Group Limited

Uploaded on

September 21, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Nasopharyngeal Carcinoma NCT01326559

English

Eligibility Nasopharyngeal Carcinoma NCT01326559

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous autologous stem cell transplantation within 6 months
Description

Transplantation of autologous hematopoietic stem cell

Data type

boolean

Alias
UMLS CUI [1]
C1831743
previous allogeneic stem cell transplantation
Description

Allogeneic Stem Cell Transplantation

Data type

boolean

Alias
UMLS CUI [1]
C2242529
more than 1 previous radio immunotherapy regimen
Description

Radioimmunotherapy Previous Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0085101
UMLS CUI [1,2]
C0205156
UMLS CUI [1,3]
C1265611
received radio immunotherapy within 3 months
Description

Radioimmunotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0085101
received any anti-cancer treatment within 4 weeks
Description

Cancer treatment

Data type

boolean

Alias
UMLS CUI [1]
C0920425
received monoclonal antibodies, other than rituximab within 3 months
Description

Monoclonal Antibodies | Exception Rituximab

Data type

boolean

Alias
UMLS CUI [1]
C0003250
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0393022
patients previously treated with anti-cd20 monoclonal antibodies, other than rituximab
Description

Anti-CD20 Antibody | Exception Rituximab

Data type

boolean

Alias
UMLS CUI [1]
C3891557
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0393022
life expectancy less than 6 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
Back to the top of the page

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01326559

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Item Group
C0680251 (UMLS CUI)
Transplantation of autologous hematopoietic stem cell
Item
previous autologous stem cell transplantation within 6 months
boolean
C1831743 (UMLS CUI [1])
Allogeneic Stem Cell Transplantation
Item
previous allogeneic stem cell transplantation
boolean
C2242529 (UMLS CUI [1])
Radioimmunotherapy Previous Quantity
Item
more than 1 previous radio immunotherapy regimen
boolean
C0085101 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Radioimmunotherapy
Item
received radio immunotherapy within 3 months
boolean
C0085101 (UMLS CUI [1])
Cancer treatment
Item
received any anti-cancer treatment within 4 weeks
boolean
C0920425 (UMLS CUI [1])
Monoclonal Antibodies | Exception Rituximab
Item
received monoclonal antibodies, other than rituximab within 3 months
boolean
C0003250 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0393022 (UMLS CUI [2,2])
Anti-CD20 Antibody | Exception Rituximab
Item
patients previously treated with anti-cd20 monoclonal antibodies, other than rituximab
boolean
C3891557 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0393022 (UMLS CUI [2,2])
Life Expectancy
Item
life expectancy less than 6 months
boolean
C0023671 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial